Mapap
NDC Package 50090-0266-3
Package Information
Mapap is do not take more than directed  AGE  DOSE  Adults and children 12 years and over  •Take 2 tablets every 4 to 6 hours while symptoms last •Do not take more than 12 tablets in 24 hours  Children 6 to 11 years  •Take 1 tablet every 4 to 6 hours while symptoms last • Do not take more than 5 tablets in 24 hours  Children under 6 yearsDo not use adult Regular Strength products in children under 6 years of age; this will provide more than the recommended dose (overdose) of  acetaminophen and may cause liver damage. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-0266 and is authorized under FDA application part343.
Identification & Billing
- RxCUI: 209375 - MAPAP 325 MG Oral Tablet
- RxCUI: 209375 - acetaminophen 325 MG Oral Tablet [Mapap]
- RxCUI: 209375 - APAP 325 MG Oral Tablet [Mapap]
- RxCUI: 209375 - Mapap 325 MG Oral Tablet
- RxCUI: 313782 - acetaminophen 325 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-0266 - Mapap
- 50090-0266-3 - 30 TABLET in 1 BOTTLE
- 50090-0266 - Mapap
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50090-0266). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-0266-3 identifies a specific commercial package of 30 tablet in 1 bottle of Mapap, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on April 21, 2011. The current certification is valid through December 31, 2019.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090026603. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.